MERS-CoV: clinical decision making support for treatment

Information for clinicians from PHE and ISARIC (International Severe Acute Respiratory & Emerging Infection Consortium).

This publication was withdrawn on

This guidance is no longer in use. For further information, please see: WHO: Middle East respiratory syndrome coronavirus (MERS-CoV).


Treatment of MERS-CoV: information for clinicians

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


An overview of available evidence and experience on investigational therapeutics for clinicians treating confirmed cases of MERS-CoV.

Published 25 June 2014
Last updated 16 August 2017 + show all updates
  1. Updated with clinical trials data and added additional sections on novel therapeutic agents undergoing investigation.

  2. Updated with version 3, September 2015.

  3. First published.